1.Clinical observation of congestive heart failure treated by integrated traditional Chinese and Western medicine.
Chinese Journal of Integrated Traditional and Western Medicine 2002;22(7):542-544
Adult
;
Aged
;
Digoxin
;
therapeutic use
;
Drug Therapy, Combination
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Heart Failure
;
drug therapy
;
Humans
;
Male
;
Middle Aged
;
Phytotherapy
3.Toward more understanding of esophagogastric cancer.
Chinese Journal of Oncology 2011;33(11):801-803
Antibodies, Monoclonal, Humanized
;
therapeutic use
;
Antineoplastic Agents
;
therapeutic use
;
Chemoradiotherapy
;
Chemotherapy, Adjuvant
;
Esophageal Neoplasms
;
classification
;
pathology
;
surgery
;
therapy
;
Esophagogastric Junction
;
Humans
;
Stomach Neoplasms
;
classification
;
pathology
;
surgery
;
therapy
;
Trastuzumab
5.Effect of BiPAP noninvasive ventilation on patients with acute left ventricular failure
Chinese Journal of Primary Medicine and Pharmacy 2009;16(5):840-841
Objective To observe the effect of Bi-level positive airway pressure(BiPAP) noninvasive ventilation on acute left ventricular failure(LVF). Methods BiPAP group :32 patients with severe LVF from various causes were treated by BiPAP with traditional drugs. Control group:32 patients were treated with traditional drugs alone,and the results were compared with those of BiPAP group. Results Dyspnea was relieved in all patients in BiPAP group,both the respiratory rate and heart rate were slowed,the vital signs were stable,and PaO2 ,SaO2 went up. The total effective rate was 100%, which was only 68. 75% in control group. Conclusion The use of BiPAP noninvasive ventilation therapy is feasible and effective on LVF.
6.An initial study of identifying and controlling episode separations
Chinese Journal of Hospital Administration 2011;27(11):863-865
ObjectiveTo imitate the process of identifying episode separations,which helps to improve the methodology of control episode separations.Methods Abstracts of inpatient record on all patients discharged from the hospitals in Beijing in 2010 were drawn from Beijing Public Health Information Center.Risk-adjusted by Diagnosis Related Groups-Beijing version (BJ-DRGs),two-weeks readmission rate was calculated at the whole city and hospital levels respectively.Comparing the readmission rate between these two levels,“suspicious objects”of episode separations can be found.In turn,the episode separations can be identified by detail analysis of these suspicious objects.Results In 2010,there were 13 DRGs with readmission rate exceeding 10%.Take the cases of dementia and other chronic brain disorders for example,the readmission rate for this type of inpatients in hospital G was much higher than the average level of the whole city.After the detail analysis of hospital G,the episode separations were found.Conclusion It is an effective method to indentify episode separations that calculating readmission rate based on the DRG risk-adjustment and using city level readmission rate as bench-mark.
7.Difference of colon cancer and rectal cancer-from the view of an oncological physician.
Chinese Journal of Oncology 2010;32(5):321-323
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Chemotherapy, Adjuvant
;
Chromosomal Instability
;
Colonic Neoplasms
;
drug therapy
;
genetics
;
pathology
;
Deoxycytidine
;
analogs & derivatives
;
therapeutic use
;
Fluorouracil
;
administration & dosage
;
analogs & derivatives
;
therapeutic use
;
Humans
;
Leucovorin
;
administration & dosage
;
Microsatellite Instability
;
Neoadjuvant Therapy
;
Neoplasm Staging
;
Organoplatinum Compounds
;
administration & dosage
;
Prognosis
;
Rectal Neoplasms
;
drug therapy
;
genetics
;
pathology
;
Risk Factors
10.More attention should be paid to the understanding of gastroenteropancreatic neuroendocrine tumors.
Chinese Journal of Oncology 2012;34(2):158-160
Antibodies, Monoclonal, Humanized
;
therapeutic use
;
Antineoplastic Agents
;
therapeutic use
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Bevacizumab
;
Gastrointestinal Neoplasms
;
classification
;
epidemiology
;
therapy
;
Humans
;
Indoles
;
therapeutic use
;
Neuroendocrine Tumors
;
classification
;
epidemiology
;
therapy
;
Octreotide
;
therapeutic use
;
Pancreatic Neoplasms
;
classification
;
epidemiology
;
therapy
;
Peptides, Cyclic
;
therapeutic use
;
Pyrroles
;
therapeutic use
;
Sirolimus
;
analogs & derivatives
;
therapeutic use
;
Somatostatin
;
analogs & derivatives
;
therapeutic use